Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.43 |
| ▸ | CHRNA10 | Q9GZZ6 | 3/20 | 0.43 |
| ▸ | CHRNA9 | Q9UGM1 | 3/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | BCHE | P06276 | 3/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28131524 | 1.00 | EGFR (0.45) | EGFRCHRNA7CHRNA10CHRNA9LTA4H | |
| SCHEMBL6313349 | 1.00 | EGFR (0.45) | EGFRCHRNA7CHRNA10CHRNA9LTA4H | |
| SCHEMBL2097271 | 1.00 | EGFR (0.45) | EGFRCHRNA7CHRNA10CHRNA9LTA4H | |
| SCHEMBL2706079 | 1.00 | EGFR (0.45) | EGFRCHRNA7CHRNA10CHRNA9LTA4H | |
| SCHEMBL7540402 | 1.00 | EGFR (0.45) | EGFRCHRNA7CHRNA10CHRNA9LTA4H | |
| SCHEMBL23244048 | 1.00 | EGFR (0.45) | EGFRCHRNA7CHRNA10CHRNA9LTA4H | |
| SCHEMBL7538355 | 1.00 | EGFR (0.45) | EGFRCHRNA7CHRNA10CHRNA9LTA4H | |
| SCHEMBL7541675 | 1.00 | EGFR (0.45) | EGFRCHRNA7CHRNA10CHRNA9LTA4H | |
| SCHEMBL21596608 | 1.00 | EGFR (0.45) | EGFRCHRNA7CHRNA10CHRNA9LTA4H | |
| SCHEMBL924663 | 0.98 | LTA4H (0.44) | EGFRCHRNA7CHRNA10CHRNA9LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257678-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2023-08-17 | — | — | US | claimed |
| EP-3746420-B1 | ENOL ETHER PROPERFUME | FIRMENICH & CIE (CH) | 2023-08-16 | — | — | EP | claimed |
| US-20210115354-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2021-04-22 | — | — | US | claimed |
| EP-3746420-A1 | ENOL ETHER PROPERFUME | Firmenich SA (CH) | 2020-12-09 | — | — | EP | claimed |
| WO-2019243501-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2019-12-26 | — | — | WO | claimed |
| US-20230257678-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2023-08-17 | — | — | US | disclosed |
| EP-3746420-B1 | ENOL ETHER PROPERFUME | FIRMENICH & CIE (CH) | 2023-08-16 | — | — | EP | disclosed |
| US-11667869-B2 | Enol ether pro perfume | FIRMENICH SA (CH) | 2023-06-06 | — | — | US | disclosed |
| US-20210115354-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2021-04-22 | — | — | US | disclosed |
| EP-3746420-A1 | ENOL ETHER PROPERFUME | Firmenich SA (CH) | 2020-12-09 | — | — | EP | disclosed |
| WO-2019243501-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2019-12-26 | — | — | WO | disclosed |
| US-6956013-B2 | Photo-activated pro-fragrances | THE PROCTER & GAMBLE COMPANY (US) | 2005-10-18 | — | — | US | disclosed |
| US-20040087454-A1 | Photo-activated pro-fragrances | PROCTER & GAMBLE COMPANY, THE | 2004-05-06 | — | — | US | disclosed |
| EP-1377538-A1 | PHOTO-ACTIVATED PRO-FRAGRANCES | THE PROCTER & GAMBLE COMPANY (US) | 2004-01-07 | — | — | EP | disclosed |
| US-20030004072-A1 | Photo-activated pro-fragrances | THE PROCTER & GAMBLE COMPANY | 2003-01-02 | — | — | US | disclosed |
| WO-2002083620-A1 | PHOTO-ACTIVATED PRO-FRAGRANCES | THE PROCTER & GAMBLE COMPANY (US) | 2002-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667869-B2 | Enol ether pro perfume | CYP2E1, ACADM, PEF1 | EGFR 3648/4885CHRNA7 2432/4885CHRNA10 3024/4885 |
| US-20230257678-A1 | ENOL ETHER PROPERFUME | CYP2E1, ADH5, ECI1 | EGFR 2703/4885CHRNA7 2343/4885CHRNA10 3157/4885 |
| US-20210115354-A1 | ENOL ETHER PROPERFUME | CYP2E1, ACADM, ALDH5A1 | EGFR 3816/4885CHRNA7 3366/4885CHRNA10 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.